Published in Cancer Weekly, January 18th, 2005
M.A. Andrykowski and colleagues, University of Kentucky, "examined the response to a transvaginal ultrasound screening (TVS) test for ovarian cancer (OC) in asymptomatic women (N=540) undergoing an initial TVS screening test. Interviews were conducted prior to undergoing TVS screening and at 2 weeks and 4 months following this baseline."
Of this group, 33 received an abnormal yet benign TVS test result. These women "reported elevated OC-specific, but not general, distress at 2-week follow-up," the researchers...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.